United Therapeutics Corporation

United Therapeutics is a biotechnology company focused on developing chronic therapies for life threatening conditions in three therapeutic areas: cardiovascular, oncology and infectious diseases. In these segments, United Therapeutics is actively developing five technology platforms: Prostacyclin Analogs, Immunotherapeutic Monoclonal Antibodies, Glycobiology, Arginine Formulations and Telemedicine.